Skip to main content

Open Access Paradigm Shift: The Realization of New Medical Alternatives to Surgery for Endometriosis

Download Article:
 Download
(HTML 75.9 kb)
 
or
 Download
(PDF 168.5 kb)
 
Endometriosis is one of the most destructive benign diseases of women. It is established as developing and being present in upward of 70% of adolescents who do not experience relief of menstrual pain with use of oral contraceptives and anti-inflammatory drugs. It occurs in 8%‐10% of women in the United States and is most prevalent in developed countries. Symptoms of endometriosis include disabling pain, hemorrhagic uterine bleeding, and infertility. Women with disease can expect a 12% hysterectomy rate. While present medical therapy may offer relief of many symptoms, there have been no major new directions in pharmacologic therapy since leuprolide acetate was made available in 1977. Danazol remains the only alternative to GnRH agonists with proven efficacy and reasonable side effects, according to Cochrane Reviews, yet, it is underused, and GnRH agonists are favored even when Danazol in combination seems more effective. A previously published case report on use of the combination of nandrolone and stanozolol to treat a young woman scheduled for hemicolectomy is discussed as an alternative to surgery along with the limits of standard therapy. This review will focus on recent research and theories seeking to establish causation for disease and offer treatment recommendations.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Endometriosis; Environmental toxins; Immunology; Nandrolone; Sex hormone binding globulin; Stanozolol; Xenoestrogens

Document Type: Research Article

Publication date: 01 December 2016

More about this publication?
  • JRM is a peer-reviewed medical journal published annually by AARM. It publishes original research, reviews, and editorials that contribute to the understanding of nutritional and botanical influence on underlying mechanisms of chronic illness. The journal was established by MichaĆ«l Friedman, ND as the founding editor. The journal's current editor-in-chief is Liz Sutherland, ND of National University of Natural Medicine.
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Terms & Conditions
  • Certification Exam
  • CME conferences
  • CME webinars
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more